Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07827586 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis

Name: Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis — clinical trial record (NCT07827586)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SONATA-MS

StatusRecruiting

PhaseNot specified

SponsorHoffmann-La Roche

Started2026-09-30

View on ClinicalTrials.gov ↗

Amendment history

2026-09-29

Recruitment opened

Roche/Genentech

364 trials monitored

See 34 trials at risk

Multiple Sclerosis

987 trials monitored

See 31 trials at risk

The main purpose of the study is to assess patient-reported satisfaction with subcutaneous (s.c.) ocrelizumab administration in participants with relapsing-remitting multiple sclerosis (RRMS) who are treatment-naive, switching from intravenous (i.v.) ocrelizumab to s.c. ocrelizumab, or switching from a prior disease-modifying therapy (DMT) to s.c. ocrelizumab.

Trial Details

NCT Number	NCT07827586
Lead Sponsor	Hoffmann-La Roche
Conditions	Relapsing-Remitting Multiple Sclerosis
Enrollment	1,800 participants
Start Date	2026-09-30
Primary Completion	2029-01-31 (estimated)
Study Completion	2029-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-28